Facultad de Farmacia y Bioquímica. Instituto de Nanobiotecnología (NANOBIOTEC), Universidad de Buenos Aires, Buenos Aires, Argentina.
Facultad de Farmacia y Bioquímica. Cátedra de Inmunología, Universidad de Buenos Aires, Buenos Aires, Argentina.
Appl Microbiol Biotechnol. 2020 Jul;104(13):5861-5872. doi: 10.1007/s00253-020-10570-7. Epub 2020 May 6.
The goal of the present work was to develop a novel reagent with potential for histoplasmosis diagnosis. For this purpose, the genetic sequence of the 100 kDa protein of Histoplasma capsulatum (Hcp100) was cloned and expressed as a secretory protein in Pichia pastoris. After optimizing the culture conditions and purifying by immobilized metal ion affinity chromatography, the highest yield of Hcp100 reached approximately 1.3 mg/l with > 90% purity in shake flasks using basal salt medium supplemented with casamino acids after 72 h of methanol induction. To investigate its potential for diagnosis, its detection in urine samples using specific polyclonal antibodies as reagent was evaluated by dot blot in 6 patients with progressive disseminated histoplasmosis (PDH), of whom all had AIDS. Antigen was detected in urine from all 6 (100%) PDH patients. Urine samples from a pool of 20 healthy individuals did not react with the anti-Hcp100 antibodies. The dot blot assay performed in this study provides preliminary data of a simple technology that can be performed in medical institutions with limited resources to facilitate the rapid diagnosis of histoplasmosis, particularly the disseminated forms. Hence, use of these assays may provide a rapid diagnostic tool of PDH in endemic areas for histoplasmosis where PDH-related mortality is high, hastening treatment and improving patient survival. Finally, this novel antigen and its specific antibodies may provide an alternative diagnostic reagent to the largely unknown and poorly characterized polysaccharide antigens (HPA, galactomannan, histoplasmin) frequently used in the diagnostic tests. KEY POINTS: Few antigens are used as laboratory tools for the immunodiagnosis of histoplasmosis. P. pastoris was an excellent system for recombinant Hcp100 expression. Maximum expression levels of rHcp100 were achieved in BSM with 1% casamino acids. Dot blot assays with anti-rHcp100 antisera can be successfully used for diagnosing PHD.
本工作的目的是开发一种具有 Histoplasma capsulatum(Hcp100)诊断潜力的新型试剂。为此,克隆了 Hcp100 的 100 kDa 蛋白的基因序列,并在毕赤酵母中作为分泌蛋白表达。在优化培养条件并通过固定化金属离子亲和层析纯化后,在使用基础盐培养基补充 1% 氨基酸的摇瓶中,在甲醇诱导 72 小时后,Hcp100 的最高产量达到约 1.3mg/l,纯度>90%。为了研究其诊断潜力,使用特异性多克隆抗体作为试剂,通过斑点印迹法检测了 6 例进行性播散性组织胞浆菌病(PDH)患者的尿液样本,其中所有患者均患有艾滋病。抗原在所有 6 例(100%)PDH 患者的尿液中均被检测到。来自 20 名健康个体的尿液样本与抗 Hcp100 抗体无反应。本研究中的斑点印迹分析提供了一种简单技术的初步数据,该技术可以在资源有限的医疗机构中进行,以方便快速诊断组织胞浆菌病,特别是播散形式。因此,在组织胞浆菌病流行地区,使用这些检测方法可能为 PDH 提供快速诊断工具,这些地区与 PDH 相关的死亡率较高,可加快治疗并提高患者生存率。最后,这种新型抗原及其特异性抗体可能为免疫诊断试验中广泛未知和特征不佳的多糖抗原(HPA、半乳甘露聚糖、组织浆菌素)提供替代诊断试剂。关键点:用于组织胞浆菌病免疫诊断的抗原很少。毕赤酵母是表达重组 Hcp100 的理想系统。在含有 1% 氨基酸的 BSM 中可实现 rHcp100 的最大表达水平。使用抗 rHcp100 抗血清的斑点印迹分析可成功用于诊断 PHD。